查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1925469

活體小動物影像系統市場（按組件、影像方式、動物種類、應用和最終用戶分類）－2026-2032年全球預測

Live Small Animal Imaging System Market by Component, Imaging Modality, Animal Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，體內小動物影像系統市場價值為 3.1548 億美元，預計到 2026 年將成長至 3.5383 億美元，到 2032 年將達到 6.7326 億美元，複合年成長率為 11.43%。

關鍵市場統計數據
基準年 2025 3.1548億美元
預計年份：2026年 3.5383億美元
預測年份 2032 6.7326億美元
複合年成長率 (%) 11.43%

全面概述當代臨床前影像平台及其在加速跨模態、跨模型和跨組織需求的轉化研究中的作用

體內小動物影像系統是轉化科學的關鍵平台技術，它透過對疾病生物學、治療反應和安全性進行非侵入性、時間序列研究，連結了臨床前發現和臨床創新。這些系統整合了硬體、軟體和服務生態系統，能夠獲得模式生物的解剖學、功能和分子資訊。檢測器靈敏度、多重模式融合和計算分析技術的進步，使得臨床前影像成為現代藥物發現流程、疾病建模和機制研究的重要組成部分。因此，研究機構、生物技術公司和受託研究機構（CRO）越來越依賴整合成像平台來加快獲得洞見的速度並提高體內實驗的準確性。

混合成像、人工智慧驅動的分析以及服務主導採購等領域的進步如何融合，從根本上重塑臨床前成像策略和營運模式？

近年來，技術進步、資料架構的演進以及對轉換應用價值的重新重視，共同促成了變革性的改變。儀器設備不再局限於漸進式改進，而是採用了融合解剖學和分子讀數的混合工作流程，使研究人員能夠從單次實驗中獲得更豐富的生物學資訊。同時，檢測器技術和重建演算法的改進提高了靈敏度和空間解析度，結合先進的軟體流程，實現了更精確的定量分析和可重複的終點結果。此外，人工智慧（AI）和機器學習在影像處理和表現型分析領域的成熟，也使工作重心從人工處理轉向自動化、可擴展的分析，從而提高了通量並減少了結果解讀的差異。

探討關稅變化對臨床前影像領域採購連續性、供應鏈韌性和整體擁有成本的影響

新關稅和貿易政策調整的實施對臨床前影像相關人員的供應鏈動態、採購計畫和成本結構產生了複雜的影響。許多儀器依賴來自供應商分散的精密組件，而關稅導致的成本增加可能會延長交貨週期，因為製造商需要重新評估其籌資策略，優先考慮在地採購，並調整供應合約。對於研究機構和服務供應商，直接影響是前置作業時間支出可能需要重新分配，並且會更加關注總體擁有成本而非初始購買價格。這促使供應商和最終用戶重新考慮維護和服務模式，以期維持運作並控制生命週期成本。

以細分市場主導，必須將各種技術優勢、生物工作流程、應用優先順序以及模組化服務和軟體產品與客戶需求相匹配。

了解細分市場趨勢對於協調產品開發、商業策略和客戶參與至關重要。影像方式涵蓋微型電腦斷層掃描（microCT）、微型磁振造影（microMRI）、微型正子斷層掃描（microPET）、微型單光子發射電腦斷層掃描（microSPECT）和光學成像，其中光學成像可細分為生物發光成像、螢光成像和光聲成像。每種影像方式都各具優勢：microCT 提供高解析度的解剖細節，microMRI 無需電離輻射即可實現軟組織對比度，microPET 和 microSPECT 可用於分子示蹤研究，而光學成像子模式則支援靈敏度的報告基因實驗和快速表現型篩檢。因此，影像方式的選擇與研究目標密切相關，許多調查計畫受益於多重模式整合，以獲得互補的終點指標。

影響採用趨勢、監管協調和區域支持需求的地理因素（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管要求和供應鏈結構。在美洲，充滿活力的學術研究生態系統和強大的生物技術產業推動了先進成像解決方案的早期應用。採購往往傾向於選擇擁有強大技術支援的綜合整合平台，服務供應商和學術核心設施也經常與業界合作，檢驗新型成像生物標記。該地區對轉化醫學的重視促進了影像專家與藥物發現和開發團隊之間的合作，加速了候選藥物從生物模型到臨床試驗的進程。

產品模組化、分析技術領先地位和卓越服務品質如何重塑臨床前影像服務供應商的差異化策略和夥伴關係模式

臨床前影像生態系統的競爭格局正在發生變化，各公司正透過平台整合、分析能力和服務模式來凸顯自身差異。領先的技術供應商正加大對模組化系統的投入，以促進多重模式工作流程，並實現無需更換整台儀器即可進行功能升級。這種模組化設計有助於延長設備使用壽命，並實現平穩的技術遷移。軟體和分析技術是另一個差異化維度。提供檢驗的流程、使用者友善介面和機器學習驅動的分析能力的供應商，正受到尋求更高可重複性和更快分析速度的客戶的青睞。服務差異化同樣重要，提供全面維護合約、遠距離診斷和結構化培訓計畫的公司，能夠提高儀器運轉率和使用者熟練度，從而建立更牢固的長期合作關係。

供應商和研究機構可透過模組化系統、穩健的供應鏈、檢驗的分析和靈活的商業模式來提升價值，可採取切實可行的步驟。

產業領導者應優先考慮將硬體創新與強大的軟體和服務生態系統結合的整合價值提案。投資支援多重模式工作流程的模組化架構，可以減少客戶升級的阻力，並拓寬其可應用的場景範圍。與硬體並行，企業應更加關注經過檢驗的分析管道和可解釋的機器學習工具，這些工具可以減少變異性並加快結果獲取速度。這種整合方法應輔以透明的整體擁有成本 (TCO) 資訊溝通，以便採購團隊能夠比較整個生命週期（而不僅僅是資本支出）中的各種方案。

本分析所依據的調查方法是嚴格的混合方法，結合專家訪談、技術文獻、專利分析和供應鏈映射，檢驗趨勢和策略要務。

本分析的調查方法結合了定性和定量方法，以確保獲得切實可行的洞見。主要研究包括對測量工程師、成像科學家、採購主管和服務經理的訪談，以收集關於技術採納、支援挑戰和採購標準的第一手觀點。次要研究包括對同行評審文獻、專利申請、監管指導文件和會議報告的全面審查，以檢驗技術趨勢和特定應用需求。此外，還進行了供應鏈映射和組件採購分析，以識別各區域潛在的瓶頸和提升韌性的機會。

整合技術、營運和政策因素，以決定臨床前影像計畫的策略方向和韌性。

臨床前影像系統正處於策略轉折點，技術創新、不斷變化的營運預期和全球貿易趨勢在此交匯融合。混合成像和分析技術的進步正在釋放更豐富、更可重複的生物學洞見，而終端用戶也日益尋求能夠降低複雜性並加速研究成果的整合解決方案。同時，關稅波動和供應鏈重組等外部壓力，促使人們迫切需要關注系統的韌性、本地支援和透明的生命週期經濟效益。這些因素共同推動相關人員採用更協作、以服務為導向的模式，強調長期夥伴關係而非交易型銷售。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 體內小動物影像系統市場（依組件分類）

  • 裝置
  • 服務
    • 維護
    • 支援服務
    • 訓練
  • 軟體

9. 依影像方式分類的體內小動物影像系統市場

  • 微型CT
  • 微型磁振造影
  • 微型PET
  • 微型SPECT
  • 光學成像
    • 生物發光成像
    • 螢光影像
    • 光聲成像

第10章 依動物類型分類的活體小動物影像系統市場

  • 小鼠模型
  • 大鼠模型
  • 斑馬魚

第11章 依應用分類的體內小動物影像系統市場

  • 循環系統
  • 藥物發現
  • 神經病學
  • 腫瘤學

第12章 依最終用戶分類的體內小動物影像系統市場

  • 學術機構
  • 生技公司
  • CRO（受託研究機構）
  • 製藥公司

第13章 區域性小型動物體內影像系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 活體小動物影像系統市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國活體小動物影像系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國活體小動物影像系統市場

第17章：中國活體小動物影像系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies Inc
  • Aspect Imaging Ltd
  • Bioscan Inc
  • Biospace Lab
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Gamma Medica Inc
  • GE Healthcare
  • Hitachi Ltd
  • Invicro LLC
  • Li-Cor Biosciences
  • Mediso Ltd
  • MILabs BV
  • MR Solutions Ltd
  • PerkinElmer Inc
  • Philips Healthcare
  • RayContrast Inc
  • Scintica Instrumentation Inc
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Sofie Biosciences Inc
  • Thermo Fisher Scientific Inc
  • Trifoil Imaging Inc
Product Code: MRR-7A380DA7C63F

The Live Small Animal Imaging System Market was valued at USD 315.48 million in 2025 and is projected to grow to USD 353.83 million in 2026, with a CAGR of 11.43%, reaching USD 673.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 315.48 million
Estimated Year [2026] USD 353.83 million
Forecast Year [2032] USD 673.26 million
CAGR (%) 11.43%

A comprehensive orientation to modern preclinical imaging platforms and their role in accelerating translational research across modalities, models, and organizational needs

The live small animal imaging system field is a critical enabler of translational science, bridging preclinical discovery and clinical innovation by enabling noninvasive longitudinal studies of disease biology, therapeutic response, and safety. These systems integrate hardware, software, and service ecosystems to capture anatomical, functional, and molecular information in model organisms. Advances in detector sensitivity, multi-modality fusion, and computational analytics have made preclinical imaging an indispensable component of modern drug discovery workflows, disease modeling, and mechanistic studies. As a result, research institutions, biotechnology innovators, and contract research organizations increasingly rely on integrated imaging platforms to reduce time-to-insight and improve the fidelity of in vivo experiments.

Within this context, the market landscape is studied across several imaging modalities including MicroCT, MicroMRI, MicroPET, MicroSPECT, and Optical Imaging, with Optical Imaging further characterized into Bioluminescence Imaging, Fluorescence Imaging, and Photoacoustic Imaging. Equally important is the diversity of animal models used to generate translationally relevant data, spanning Mouse Models, Rat Models, and Zebrafish, each offering distinct advantages in throughput, genetic tractability, and cost. Applications center on cardiovascular research, drug discovery programs, neurology investigations, and oncology studies, with end users ranging from academic institutes to biotechnology companies, contract research organizations, and pharmaceutical companies. Finally, the component landscape comprises Instruments, Services, and Software, where services include Maintenance, Support Services, and Training. Together, these interrelated segments shape procurement priorities, operational models, and the adoption curve for advanced imaging capabilities.

This introduction sets the stage for a deeper exploration of technological inflection points, regulatory and trade dynamics, and strategic imperatives that are redefining how organizations invest in and deploy preclinical imaging assets. By framing the field through modality, model organism, application, end user, and component lenses, stakeholders can better align investments with scientific objectives and institutional capacity.

How converging advances in hybrid imaging, AI-driven analytics, and service-driven procurement are fundamentally reshaping preclinical imaging strategies and operational models

The last several years have seen transformative shifts driven by converging technological advancements, evolving data architectures, and a renewed emphasis on translational relevance. Instrumentation has moved beyond incremental improvements to embrace hybrid workflows that fuse anatomical and molecular readouts, enabling researchers to derive richer biological context from single experimental sessions. Meanwhile, improvements in detector technology and reconstruction algorithms have increased sensitivity and spatial resolution, which, when paired with sophisticated software pipelines, allow for more precise quantification and reproducible endpoints. In parallel, the maturation of artificial intelligence and machine learning for image processing and phenotypic analysis is shifting labor from manual curation toward automated, scalable analytics, thereby increasing throughput and reducing interpretive variability.

Another major shift concerns operational models and service delivery. Organizations are prioritizing outcome-oriented partnerships with vendors that offer not only instruments but also long-term support, training, and managed services that lower the barrier to adoption. This trend is reinforced by the need for standardized protocols that enhance data comparability across multi-center studies and by a focus on interoperability between imaging modalities and laboratory information systems. Regulatory and ethical considerations are also influencing system design and study planning, with noninvasive imaging techniques increasingly preferred for their ability to reduce animal use through longitudinal measures and refine endpoint selection. Collectively, these technological, operational, and ethical shifts are reshaping value propositions across the preclinical imaging ecosystem and prompting stakeholders to reassess capital allocation, talent development, and collaborative strategies.

Navigating the implications of shifting tariff regimes on procurement continuity, supply chain resilience, and total cost of ownership for preclinical imaging portfolios

The introduction of new tariff measures and trade policy adjustments has created a complex overlay on supply chain dynamics, procurement planning, and cost structures for preclinical imaging stakeholders. Many instruments rely on precision components sourced from geographically dispersed suppliers, and tariff-induced cost inflation can lead to extended lead times as manufacturers reevaluate sourcing strategies, prioritize local content, or adjust supplier contracts. For research institutions and service providers, the immediate consequence is a potential reallocation of capital expenditures and a heightened focus on total cost of ownership rather than initial purchase price. Vendors and end users alike are therefore revisiting maintenance and service models to preserve uptime and manage lifecycle expenses.

Moreover, tariffs amplify the strategic importance of regional manufacturing footprints and distribution networks. Organizations with established local assembly or aftermarket support capabilities can reduce exposure to cross-border tariffs, whereas those dependent on fully imported systems may face higher landed costs and scheduling uncertainty. In response, some suppliers are accelerating localization of key subassemblies and strengthening regional partnerships to de-risk deliveries. From a software and training perspective, the impact is different but still material: licensing arrangements, cloud service dependencies, and remote training programs may incur indirect costs or administrative hurdles tied to regional compliance requirements. Ultimately, the cumulative effect of tariff measures prompts a reappraisal of procurement timing, inventory buffers, and supplier diversification strategies, compelling decision-makers to balance near-term operational continuity against longer-term investments in resilience.

Segment-driven imperatives for aligning modality strengths, organism workflows, application priorities, and modular service and software offerings to customer needs

Understanding segmentation dynamics is essential for aligning product development, commercial strategy, and customer engagement. The imaging modality landscape spans MicroCT, MicroMRI, MicroPET, MicroSPECT, and Optical Imaging, with Optical Imaging further delineated into Bioluminescence Imaging, Fluorescence Imaging, and Photoacoustic Imaging. Each modality delivers unique strengths: MicroCT provides high-resolution anatomical detail, MicroMRI offers soft-tissue contrast without ionizing radiation, MicroPET and MicroSPECT enable molecular tracer studies, and optical submodalities support sensitive reporter-based experiments and rapid phenotypic screening. Modality choice is therefore tightly coupled to study objectives, with many research programs benefitting from multi-modality integration to capture complementary endpoints.

Animal type choice is another determinant of experimental design, as Mouse Models, Rat Models, and Zebrafish each present trade-offs in genetic manipulability, physiological relevance, throughput potential, and handling complexity. These model organism decisions influence instrumentation configuration, imaging protocols, and throughput expectations. Application-focused segmentation highlights where imaging delivers the most value: cardiovascular research, drug discovery efforts, neurology investigations, and oncology studies frequently leverage imaging-derived biomarkers to track disease progression and therapeutic response. End users-academic institutes, biotechnology companies, contract research organizations, and pharmaceutical companies-exhibit distinct purchasing behaviors, budget cycles, and service expectations, which require tailored commercial and support models.

Finally, components define the revenue and engagement lifecycle: Instruments, Services, and Software. Within services, Maintenance, Support Services, and Training are critical to sustaining instrument uptime and ensuring data quality. Software investments span acquisition, image reconstruction, analytics, and laboratory integration, and the right combination of software and services often dictates long-term customer satisfaction. Insights from segmentation analysis therefore recommend harmonizing product roadmaps with modality strengths, model organism workflows, application needs, and end-user operational constraints, while delivering modular service and software options that scale with customer maturity.

Geographic considerations shaping adoption, regulatory alignment, and localized support requirements across the Americas, Europe Middle East Africa, and Asia Pacific

Regional dynamics influence adoption patterns, regulatory expectations, and supply chain configurations across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, vibrant academic research ecosystems and a robust biotech sector support early adoption of advanced imaging solutions. Procurement tends to favor comprehensive, integrated platforms backed by strong technical support, and service providers and academic cores often collaborate with industry to validate novel imaging biomarkers. This region's emphasis on translational pipelines encourages partnerships between imaging specialists and drug development teams to accelerate candidate progression from in vivo models to clinical trials.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, national funding models, and research priorities vary considerably. Established centers of excellence in oncology and neuroscience drive demand for high-end imaging modalities, while collaborative consortia emphasize standardization and cross-site reproducibility. In this region, service and training offerings that support protocol harmonization and cross-laboratory comparability are particularly valued. In contrast, Asia-Pacific demonstrates rapid expansion in both R&D capacity and local manufacturing capabilities. Investment in regional fabrication and aftermarket support is increasing, enabling faster delivery cycles and more cost-competitive service packages. Across these geographies, regional policy, talent availability, and logistical infrastructure shape procurement choices, with organizations often selecting partners who can demonstrate regulatory knowledge, localized support, and an ability to scale operations across complex multi-site studies.

How product modularity, analytics leadership, and service excellence are reshaping differentiation strategies and partnership models among preclinical imaging providers

Competitive dynamics in the preclinical imaging ecosystem are evolving as companies differentiate along platform integration, analytics capability, and service models. Leading technology providers are investing in modular systems that facilitate multi-modality workflows and enable customers to upgrade functionality without full instrument replacement. This modularity supports longer asset lifespans and smoother technology transitions. Another axis of differentiation is software and analytics: vendors that provide validated pipelines, user-friendly interfaces, and machine learning-enabled analytics gain traction with customers seeking reproducibility and reduced analysis timelines. Service differentiation is equally important; companies offering comprehensive maintenance contracts, remote diagnostics, and structured training programs enhance instrument uptime and user competency, which fosters stronger long-term relationships.

Strategic partnerships and collaborations are also reshaping the landscape. Alliances between instrument providers and contract research organizations or academic centers create co-development opportunities for novel tracers, imaging biomarkers, and standardized protocols. Additionally, some vendors are exploring subscription or pay-per-use models that reduce upfront barriers to adoption for emerging research groups, while larger institutions continue to evaluate total cost of ownership and lifecycle support. Overall, companies that balance product innovation with scalable service delivery and clear pathways for software integration are best positioned to meet the diverse needs of end users in academic, biotech, CRO, and pharmaceutical settings.

Practical steps for vendors and research organizations to enhance value through modular systems, resilient supply chains, validated analytics, and flexible commercial models

Industry leaders should prioritize an integrated value proposition that pairs hardware innovation with robust software and service ecosystems. Investing in modular architectures that support multi-modality workflows will reduce customer friction during upgrades and enable a broader addressable use case set. Alongside hardware, organizations must commit to validated analytics pipelines and explainable machine learning tools that reduce variability and accelerate time-to-result. This integrated approach should be complemented by transparent total cost of ownership communications that help procurement teams compare lifecycle options rather than just capital expenditure figures.

Operationally, companies and end users should strengthen supply chain resilience by diversifying suppliers, increasing local content where feasible, and maintaining strategic inventory buffers for critical subsystems. Service leaders should expand remote diagnostic capabilities and virtual training programs to support distributed user bases and minimize downtime. On the commercial front, adopting flexible commercial models-such as usage-based access, bundled service contracts, and tiered support-can lower adoption barriers and create recurring revenue streams. Finally, stakeholders must invest in standardized protocols and cross-site validation initiatives to enhance data interoperability and support multi-center studies, thereby increasing the translational value of imaging-derived biomarkers.

A rigorous mixed-methods approach combining expert interviews, technical literature, patent analysis, and supply chain mapping to validate trends and strategic imperatives

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure robust, actionable insights. Primary research included interviews with instrumentation engineers, imaging scientists, procurement leads, and service managers to capture firsthand perspectives on technology adoption, support challenges, and purchasing criteria. Secondary research involved a comprehensive review of peer-reviewed literature, patent filings, regulatory guidance documents, and conference proceedings to validate technological trends and application-specific requirements. Additionally, supply chain mapping and component sourcing analyses were conducted to identify potential bottlenecks and resilience opportunities across regions.

Data validation employed triangulation across multiple sources, reconciling operator interviews with technical specifications and vendor documentation. Scenario analysis was used to test the impact of trade policy shifts and supply disruptions on procurement timelines and service delivery. Finally, segmentation frameworks were applied to ensure insights were actionable for stakeholders aligned by modality, model organism, application, end user, and component, with special attention to the nuances within optical imaging submodalities and services. This mixed-methods approach provides a balanced view of technological trajectories, operational constraints, and strategic options for market participants.

Synthesis of technological, operational, and policy factors that will determine the strategic direction and resilience of preclinical imaging initiatives

Preclinical imaging systems sit at a strategic inflection point where technological innovation, evolving operational expectations, and global trade dynamics intersect. Advances in hybrid imaging and analytics are unlocking richer, more reproducible biological insights, while end users increasingly demand integrated solutions that reduce complexity and accelerate research outcomes. At the same time, external pressures such as tariff shifts and supply chain reconfiguration necessitate a sharper focus on resilience, localized support, and transparent lifecycle economics. These forces collectively encourage stakeholders to adopt more collaborative, service-oriented models that emphasize long-term partnerships over transactional sales.

Looking ahead, organizations that invest in modular platforms, validated analytics, strong service networks, and diversified supply chains will be better positioned to sustain research continuity and derive maximum value from imaging investments. Standardization and cross-site harmonization will further enhance the translational impact of imaging biomarkers, enabling more effective multi-center studies and collaborative drug development programs. In sum, the trajectory of preclinical imaging favors integrated, resilient, and data-driven approaches that align technological capability with operational practicality and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Live Small Animal Imaging System Market, by Component

  • 8.1. Instruments
  • 8.2. Services
    • 8.2.1. Maintenance
    • 8.2.2. Support Services
    • 8.2.3. Training
  • 8.3. Software

9. Live Small Animal Imaging System Market, by Imaging Modality

  • 9.1. MicroCT
  • 9.2. MicroMRI
  • 9.3. MicroPET
  • 9.4. MicroSPECT
  • 9.5. Optical Imaging
    • 9.5.1. Bioluminescence Imaging
    • 9.5.2. Fluorescence Imaging
    • 9.5.3. Photoacoustic Imaging

10. Live Small Animal Imaging System Market, by Animal Type

  • 10.1. Mouse Models
  • 10.2. Rat Models
  • 10.3. Zebrafish

11. Live Small Animal Imaging System Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Drug Discovery
  • 11.3. Neurology
  • 11.4. Oncology

12. Live Small Animal Imaging System Market, by End User

  • 12.1. Academic Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical Companies

13. Live Small Animal Imaging System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Live Small Animal Imaging System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Live Small Animal Imaging System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Live Small Animal Imaging System Market

17. China Live Small Animal Imaging System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies Inc
  • 18.6. Aspect Imaging Ltd
  • 18.7. Bioscan Inc
  • 18.8. Biospace Lab
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. Gamma Medica Inc
  • 18.13. GE Healthcare
  • 18.14. Hitachi Ltd
  • 18.15. Invicro LLC
  • 18.16. Li-Cor Biosciences
  • 18.17. Mediso Ltd
  • 18.18. MILabs BV
  • 18.19. MR Solutions Ltd
  • 18.20. PerkinElmer Inc
  • 18.21. Philips Healthcare
  • 18.22. RayContrast Inc
  • 18.23. Scintica Instrumentation Inc
  • 18.24. Shimadzu Corporation
  • 18.25. Siemens Healthineers AG
  • 18.26. Sofie Biosciences Inc
  • 18.27. Thermo Fisher Scientific Inc
  • 18.28. Trifoil Imaging Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 184. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 186. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 192. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 195. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)